http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2797350-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_139aff3556869a0208383f5dac575e98
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb72c33e15cf38fed88321150cb30be1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7707d8e7c170157af86b45c63cc9e64e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2445e0135ba8105e07228d723416d14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93bfa63db0ed8150aeb21387212b6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b018e197c7086a64b2942d0c14d96e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6ed6225077a945c4b0ae9c5db5026e
publicationDate 2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2797350-A1
titleOfInvention Co-crystal intermediates of rosuvastatin and methods of using same
abstract which include such co-crystals and methods for treating conditions associated with hyper-cholesterolemia Methods for the preparation of Rosuvastatin by co-crystals of Rosuvastatin or intermediates are provided. Also provided are co-crystals, pharmaceutical compositions by administering such compositions.
priorityDate 2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53486317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414092084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413649047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450470952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452336560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453199245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71582050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69483014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452005138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29918986

Total number of triples: 52.